Cloud DX (TSX-V:CDX, OTCQB:CDXFF) Inc said its virtual care platform, Connected Health has been recognized by the Natural Sciences and Engineering Research Council of Canada (NSERC) as co-recipient of its Synergy Award of Innovation.
Presented to Dr Edwards Sykes of Sheridan College and Cloud DX (TSX-V:CDX, OTCQB:CDXFF), the award recognizes the company's patented ‘augmented reality' (AR) platform: ‘The Clinic of the Future', which uses comprehensive vital sign and physiological data from the Vitaliti continuous monitoring platform to display real-time patient information in the form of 3D holographic images, offering a fully remote, touchless yet seamless way to interact with patients.
The prestigious award provides $100,000 to the college and $20,000 to Cloud DX as the co-winning private vendor to continue commercializing the Clinic of the Future.
READ: Cloud DX has officially launched its Maternal Health Track program on e-commerce site babydoppler.com
The company was additionally just recognized by the Ontario Center of Innovation as a winner of the competitive Ontario Innovation Showcase. Of eighteen competing companies, the Showcase awarded the five winners with $50,000 in direct funding to improve and validate technology that enhances the province's critical health and security infrastructure.
"Cloud DX is very proud to accept these awards to support the commercialization of our patented innovations including Vitaliti™ and Connected Health™, in order to improve healthcare delivery across North America. Cloud DX will use this new funding to further study the impact remote care has on reducing re-admissions, generating sustainable savings for healthcare systems, and improving patient outcomes," says Robert Kaul, CEO and founder of Cloud DX in a statement.
"The NSERC and OCI awards are recognitions of Canadian technology excellence that advance our MedTech industry. Research, testing, and published, peer-reviewed studies are leading us to the future - one where we see virtual and remote care, AI, and Augmented Reality embedded throughout the healthcare delivery," he added.
Cloud DX's recent achievements come just weeks after a previously award-winning and funded project (PVC-RAM 1) published its findings on improved outcomes of remote monitoring in the prestigious British Journal of Medicine. Cloud DX continues to strongly support research as a pillar of its business in leading and supporting health technology innovations.
Cloud DX will host an investor meeting at 12.00pm ET on December 8, 2021, where its leadership will discuss Virtual Care as a Platform and associated revenue streams. Investors can register for the meeting via the following link: https://zoom.us/webinar/register/1916365021520/WN_qWJGYDBxROO_lfiUJ9-8ow
Accelerating virtual healthcare, Cloud DX is on a mission to make healthcare better for everyone. Its Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home.
The company's partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources.
Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company 'World Changing Idea' finalist, and one of 'Canada's Ten Most Prominent Telehealth Providers'.
Contact the author at jon.hopkins@proactiveinvestors.com